JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shinobu, N.
Right arrow Articles by Hatakeyama, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shinobu, N.
Right arrow Articles by Hatakeyama, M.

J Biol Chem, Vol. 274, Issue 24, 17003-17010, June 11, 1999

Physical Interaction and Functional Antagonism between the RNA Polymerase II Elongation Factor ELL and p53

Noriaki Shinobu, Tatsuya Maeda, Teijiro Aso, Tohru Ito, Takuma Kondo, Katsuro KoikeDagger , and Masanori Hatakeyama

From the Departments of Viral Oncology and Dagger  Gene Research, Cancer Institute, Japanese Foundation for Cancer Research, 1-37-1 Kami-Ikebukuro, Toshima-ku, Tokyo 170-8455, Japan

ELL was originally identified as a gene that undergoes translocation with the trithorax-like MLL gene in acute myeloid leukemia. Recent studies have shown that the gene product, ELL, functions as an RNA polymerase II elongation factor that increases the rate of transcription by RNA polymerase II by suppressing transient pausing. Using yeast two-hybrid screening with ELL as bait, we isolated the p53 tumor suppressor protein as a specific interactor of ELL. The interaction involves respectively the transcription elongation activation domain of ELL and the C-terminal tail of p53. Through this interaction, ELL inhibits both sequence-specific transactivation and sequence-independent transrepression by p53. Thus, ELL acts as a negative regulator of p53 in transcription. Conversely, p53 inhibits the transcription elongation activity of ELL, suggesting that p53 is capable of regulating general transcription by RNA polymerase II through controlling the ELL activity. Elevated levels of ELL in cells resulted in the inhibition of p53-dependent induction of endogenous p21 and substantially protected cells from p53-mediated apoptosis that is induced by genotoxic stress. Our observations indicate the existence of a mutually inhibitory interaction between p53 and a general transcription elongation factor ELL and raise the possibility that an aberrant interaction between p53 and ELL may play a role in the genesis of leukemias carrying MLL-ELL gene translocations.

Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
M. Mattia, V. Gottifredi, K. McKinney, and C. Prives
p53-Dependent p21 mRNA Elongation Is Impaired when DNA Replication Is Stalled
Mol. Cell. Biol., February 15, 2007; 27(4): 1309 - 1320.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. A. Gerber, A. Shilatifard, and J. C. Eissenberg
Mutational Analysis of an RNA Polymerase II Elongation Factor in Drosophila melanogaster
Mol. Cell. Biol., September 1, 2005; 25(17): 7803 - 7811.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
D. Wiederschain, H. Kawai, J. Gu, A. Shilatifard, and Z.-M. Yuan
Molecular Basis of p53 Functional Inactivation by the Leukemic Protein MLL-ELL
Mol. Cell. Biol., June 15, 2003; 23(12): 4230 - 4246.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Del Poeta, A. Venditti, M. I. Del Principe, L. Maurillo, F. Buccisano, A. Tamburini, M. C. Cox, A. Franchi, A. Bruno, C. Mazzone, et al.
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)
Blood, March 15, 2003; 101(6): 2125 - 2131.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. D. Schimmer, D. W. Hedley, L. Z. Penn, and M. D. Minden
Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view
Blood, December 15, 2001; 98(13): 3541 - 3553.
[Full Text] [PDF]

Home page
 BloodHome page
F. Simone, P. E. Polak, J. J. Kaberlein, R. T. Luo, D. A. Levitan, and M. J. Thirman
EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein
Blood, July 1, 2001; 98(1): 201 - 209.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
R. W. Johnstone, M. Gerber, T. Landewe, A. Tollefson, W. S. Wold, and A. Shilatifard
Functional Analysis of the Leukemia Protein ELL: Evidence for a Role in the Regulation of Cell Growth and Survival
Mol. Cell. Biol., March 1, 2001; 21(5): 1672 - 1681.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
T. Miller, K. Williams, R. W. Johnstone, and A. Shilatifard
Identification, Cloning, Expression, and Biochemical Characterization of the Testis-specific RNA Polymerase II Elongation Factor ELL3
J. Biol. Chem., October 6, 2000; 275(41): 32052 - 32056.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Kondo, H. Higashi, H. Nishizawa, S. Ishikawa, S. Ashizawa, M. Yamada, Z. Makita, T. Koike, and M. Hatakeyama
Involvement of pRB-related p107 Protein in the Inhibition of S Phase Progression in Response to Genotoxic Stress
J. Biol. Chem., May 11, 2001; 276(20): 17559 - 17567.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.